Your browser doesn't support javascript.
loading
Defining pre-emptive living kidney donor transplantation as a quality indicator.
Wang, Carol; Garg, Amit X; Luo, Bin; Kim, S Joseph; Knoll, Gregory; Yohanna, Seychelle; Treleaven, Darin; McKenzie, Susan; Ip, Jane; Cooper, Rebecca; Elliott, Lori; Naylor, Kyla L.
  • Wang C; Division of Nephrology, Western University, London, Ontario, Canada. Electronic address: carol.wang@lhsc.on.ca.
  • Garg AX; Division of Nephrology, Western University, London, Ontario, Canada; ICES, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Lawson Health Research Institute and London Health Sciences Centre, London, Ontario, Canada.
  • Luo B; ICES, Ontario, Canada; Lawson Health Research Institute and London Health Sciences Centre, London, Ontario, Canada.
  • Kim SJ; Division of Nephrology and the Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.
  • Knoll G; University of Ottawa, Department of Medicine (Nephrology) and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Yohanna S; Division of Nephrology, McMaster University, Hamilton, Ontario, Canada.
  • Treleaven D; Division of Nephrology, McMaster University, Hamilton, Ontario, Canada.
  • McKenzie S; Kidney Patient & Donor Alliance, Canada.
  • Ip J; Ontario Renal Network, Ontario Health, Ontario, Canada.
  • Cooper R; Ontario Renal Network, Ontario Health, and Trillium Gift of Life Network, Ontario Health, Canada.
  • Elliott L; Ontario Renal Network, Ontario Health, Ontario, Canada.
  • Naylor KL; ICES, Ontario, Canada; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada; Lawson Health Research Institute and London Health Sciences Centre, London, Ontario, Canada.
Am J Transplant ; 2024 Feb 22.
Article en En | MEDLINE | ID: mdl-38395149
ABSTRACT
Quality indicators in kidney transplants are needed to identify care gaps and improve access to transplants. We used linked administrative health care databases to examine multiple ways of defining pre-emptive living donor kidney transplants, including different patient cohorts and censoring definitions. We included adults from Ontario, Canada with advanced chronic kidney disease between January 1, 2013, to December 31, 2018. We created 4 unique incident patient cohorts, varying the eligibility by the risk of progression to kidney failure and whether individuals had a recorded contraindication to kidney transplant (eg, home oxygen use). We explored the effect of 4 censoring event definitions. Across the 4 cohorts, size varied substantially from 20 663 to 9598 patients, with the largest reduction (a 43% reduction) occurring when we excluded patients with ≥1 recorded contraindication to kidney transplantation. The incidence rate (per 100 person-years) of pre-emptive living donor kidney transplant varied across cohorts from 1.02 (95% CI 0.91-1.14) for our most inclusive cohort to 2.21 (95% CI 1.96-2.49) for the most restrictive cohort. Our methods can serve as a framework for developing other quality indicators in kidney transplantation and monitoring and improving access to pre-emptive living donor kidney transplants in health care systems.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article